UCSF University of California, San Francisco
About UCSF
UCSF Children's Hospital
Search

Welcome

Hospitals and Clinics

Appointments

Billing

Directions

Gift Shops

Health Insurance

Medical Records

Patient Mail

Phone Numbers

Visiting Hours

...and more

Doctor Directory

Appointments

Health Insurance

Overview

A-Z Conditions

Arthritis

Bone Marrow Transplant

Cancer

Children's Services

Clinical Laboratories

Heart Care

Hormonal Disorders

Memory Disorders

Neurological Disorders

Organ Transplants

Orthopedics

Primary Care

Radiology

Women's Health

...and more

Overview

Clinical Trials

Conditions

Events and Classes

Medical Dictionary

Medical Tests

News

Patient Education

Publications

Research

Specialized Services

Other Resources

Overview

Billing

Clinical Trials

Consultations

Continuing Education

Health Insurance

News

Outreach Clinics

Publications

Referrals

Transfers

UCSF Medical Group

Patient Guide Find a Doctor Medical Services Health Library For Health Professionals

Medical Services

Prenatal Diagnosis

Cystic Fibrosis

Signs and Symptoms
Diagnosis
Treatment

Diagnosis

Screening

Carrier testing, which is performed by a blood test, can detect mutations in the cystic fibrosis gene. There are over 800 genetic changes or mutations that are known to cause CF. Some CF carriers have rare mutations, which will be missed by the test. Genetic testing for carrying the gene detects 85 percent to 90 percent of the gene changes known to cause CF among Caucasians. Genetic testing identifies a higher percentage - about 95 percent -- of carriers in the Ashkenazi Jewish population, but fewer carriers in other ethnic groups. Screening is also available for other ethnic groups but is able to identify fewer carriers because many mutations have not yet been identified.

A negative carrier test does not eliminate the chance you may carry the CF gene, but can lower that chance. Some people have rare CF mutations that cannot be detected by the routine testing available. There is a small chance that someone with a negative test could be a carrier and have a child with CF.

Diagnostic Test

Chorionic Villus Sampling

Chorionic villus sampling (CVS) can detect chromosomal problems such as Down syndrome as well as other genetic diseases such as cystic fibrosis, Tay-Sachs disease and sickle cell disease in at-risk fetuses. An advantage of CVS over amniocentesis is that it is done much earlier in pregnancy, at 10 to 12 weeks, rather than at 15 to 20 weeks.

The CVS procedure involves removing a tiny piece of tissue from the placenta. Under ultrasound guidance, the tissue is obtained either with a needle through the abdomen or a catheter inserted through the cervix. The tissue is then cultured and a karyotype analysis - an analysis of the chromosomal make-up of the cells -- is performed. It takes about two weeks to receive the results.

Because the test can be performed much earlier in pregnancy, results are typically available by the end of the third month. There is a small risk of miscarriage as a result of CVS -- 1 in 100 or less. Miscarriage rates for procedures performed at UCSF Medical Center are less than 1 in 200.

For more information, please see:

 

Reviewed by health care specialists at UCSF Medical Center.
Last updated August 19, 2009

Print Format Email This Page
Home | About the Medical Center | Contact Us | Jobs | Compliance / Hotline
Copyright © 2002 - 2009 The Regents of the University of California | Terms of Use | Site Map